The study reviewed 157 medical records, with the majority of patients were predominantly female (63.7%), aged 63.0 years, and from the Greater Sydney region (86.6%). Most patients were born in Australia (66.9%) , with 17.8% stating previous cannabis use and having neurological (58.0%) or musculoskeletal (24.8%) conditions.
Thursday, 6 April 2023
"The Effectivenes of Medicinal Cannabis in Adults with Non-Cancer Diagnoses"
Monday, 6 March 2023
CBD & Yoga "A Perfect Combination"
Monday, 9 January 2023
Arizona Supreme Court: "Maternal Use of Cannabis for Morning Sickness Doesn’t Constitute Child Neglect"
Friday, 5 August 2022
"The use of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients"
Traditionally, cancer-related pain is mainly treated by opioid analgesics but a promising substitute for opioid-based medication is Medical Cannabis (MC) and Cannabinoid treatment for cancer-related pain is generally recognized as safe!
Despite the fact that there is a knowledge gap in the study of Cannabis, especially for treating cancer-related pain, a 2020 study showed that most cancer patients requested MC treatment from their oncologist.
The Adverse Effects (AEs) from cannabinoids for cancer treatment are generally well tolerated by the patients and categorized as mild to moderate and the most frequent AEs are memory impairment, drowsiness, nausea, vomiting and xerostomia (dry mouth).
This long-term study was conducted between January 2019 and September 2021 in Israel and pulished in Frontiers in Pain Research on 20 May 2022.
Saturday, 21 May 2022
"Grant funds to researchers who are studying cannabis treatment for cancer"
The "National Institutes of Health" (NIH) is prepping to grant funds to researchers who are studying cannabis treatment for cancer and will soon be available to researchers who are working to treat cannabis.
Within the US, many states have permitted the use of cannabis products, but state policies vary widely regarding the types of products allowed and for what purpose they may be used. Concurrently, the delivery methods of cannabis have diversified and now include edibles, oils, tinctures, topicals and inhaled forms.
Cancer patients use cannabis and cannabinoids to manage symptoms of cancer and cancer treatment including anorexia, nausea, and pain. Recent survey evidence suggests that a quarter of cancer patients have used cannabis for symptom management. Despite the increase in cannabis and cannabinoid use, research about their health effects, including potential harms and benefits, remain limited.